Menopause without fear: the power of functional foods to regain balance without synthetic hormones

Perimenopause represents a complex neuroendocrine transition phase of variable duration (often several years), characterized by a progressive and inexorable reduction in the ovarian follicular reserve. From an endocrinological perspective, the decline in ovarian steroid function entails a marked reduction in blood estradiol levels, associated with a compensatory hypersecretion of pituitary gonadotropins, clinically evident through elevated levels of FSH (Follicle-Stimulating Hormone) and LH (Luteinizing Hormone).

This pattern of relative and absolute hypoestrogenism results in menstrual cycle irregularity—ranging from closely spaced or widely spaced cycles (oligoamenorrhea) to overt amenorrhea—frequent anovulatory cycles, and a characteristic constellation of symptoms. Among the most disabling disorders are vasomotor symptoms (hot flashes, accompanied by sudden profuse sweating, both during the day and at night) and mood fluctuations.

Therapeutic Rationale: Beyond Hormone Replacement Therapy

Hormone Replacement Therapy (HRT) with estrogens or progestins represents the conventional first-line pharmacological strategy. However, international organizations such as the Food and Drug Administration (FDA) and the American Association of Clinical Endocrinologists (AACE) recommend strictly selective prescribing. HRT is primarily indicated for premature menopause and physiological menopause with highly disabling symptoms, suggesting that the lowest effective dose be used for the shortest possible duration. This stems from the need to minimize the risk of serious estrogen-dependent conditions, including venous thromboembolic disease, breast, endometrial, and ovarian cancer, as well as hepatic adenomas.

In light of these limitations, integrative medicine and clinical nutrition offer a preventive and supportive approach. The early, structured use of functional foods, herbal medicines, vitamins, and minerals pursues two primary objectives:

• Symptomatic: Alleviate vasomotor disorders, dryness, gynecological issues, emotional instability, anxiety-depressive states, and sleep disorders.
• Preventive: Mitigate cardiometabolic risk (visceral obesity, metabolic syndrome, insulin resistance, myocardial infarction) and preserve bone mineral density against osteoporosis.

Nutraceutical and Clinical Analysis of Functional Foods

Avena Sativa: Metabolic and Neurochemical Modulation

Common oats (Avena sativa, family Gramineae) stand out among cereals for their nutritional density: they contain approximately 12% protein, 7% lipids, 64% carbohydrates, and between 12% and 14% dietary fiber. Their mineral profile is characterized by high concentrations of calcium, magnesium, potassium, silicon, and iron, which provide significant remineralizing properties, complemented by a substantial supply of vitamin B1.

The bioactive component of oats acts at multiple levels:

• Neurochemical Activity: It contains two specific alkaloids: gramine, an indole compound capable of interacting by modulating gamma-aminobutyric acid (GABA) receptors, and avenalumina, which positively stimulates catecholamine metabolism, contributing to the stabilization of mood.
• Lipid Profile and Cardiovascular Risk: Triterpenoids and steroidal saponins (avenacosides A and B, avenacins) act synergistically with beta-glucan, a highly viscous soluble fiber whose effectiveness in lowering blood cholesterol has been documented since 1963. EU Regulation 432/2012 officially recognizes health claims for oat beta-glucan: a daily intake of at least 3 grams contributes to maintaining normal blood cholesterol levels, reducing a primary risk factor for coronary heart disease.
• Antioxidant and Immune Protection: Oats synthesize unique polyphenols called avenanthramides, which possess a pronounced antioxidant action and are capable of inhibiting the peroxidation of LDL particles and preventing the formation of free radicals at the endothelial level. Furthermore, the selenium content acts as an essential cofactor for glutathione peroxidase (GPx), a crucial enzyme in neutralizing hydrogen peroxide. In combination with vitamin E, selenium supports DNA repair mechanisms, contributing to a reduced risk of cancer, particularly colon cancer. Epidemiological studies also indicate that an adequate intake of fiber from Avena sativa provides significant protection against premenopausal breast cancer.
• Weight Management and Clinical Responses: Thanks to its low/medium glycemic index and beta-glucan's ability to delay gastric emptying, oats promote satiety and improve intestinal function. In a study conducted on obese postmenopausal women, the administration of 28 grams of oats daily for four weeks resulted in an 11.2% increase in plasma HDL, demonstrating its value within the overall framework of cardiovascular prevention.

Green Tea (Camellia sinensis): Anticancer and Neuro-Metabolic Properties

Green tea represents a primary source of flavan-3-ols, specifically catechins with high radical-scavenging activity. The most therapeutically relevant molecule is epigallocatechin gallate (EGCG), recognized as a powerful anticancer and anti-aging agent capable of modulating cellular inflammatory pathways.

Watermelon (Citrullus lanatus): Endothelial Function and Vascular Protection

Watermelon is a fruit with a very high hydrating power (composed of approximately 94% water), whose nutritional value is linked to the presence of active principles essential for vascular health:

1. L-citrulline: Amino acid precursor of L-arginine, essential for the endothelial nitric oxide (NO) synthesis pathway. Recent clinical evidence indicates that the administration of watermelon extracts induces a reduction in arterial stiffness (arterial stiffness) and central aortic pressure in obese postmenopausal women suffering from grade I arterial hypertension.
2. Lycopene: Lipophilic carotenoid with a very high antioxidant capacity, effective in blocking reactive oxygen species (ROS) and countering cellular mutagenesis processes.

Soy Isoflavones and (S)-Equol: Replacement Phytoestrogens

The isoflavones extracted from soy, mainly genistein and daidzein, have a structural conformation similar to that of 17-β-estradiol. This analogy allows them to bind to human estrogen receptors (ERα and ERβ), acting as Selective Estrogen Receptor Modulators (natural-derived SERMs).

Their action is dual and dependent on the endocrine hormonal context:

• In conditions of hypoestrogenism (such as in pre-menopause and menopause), they act as weak estrogen agonists, partially compensating for the hormonal deficiency and reducing hypothalamic instability.
• In the presence of physiological or high levels of estrogens, they compete for the same receptors behaving as weak antagonists, exerting a potential protection on hormone-dependent tissues.

Scientific research highlights that the clinical association between soy isoflavones and berberine not only reduces vasomotor symptoms, but improves the plasma lipid profile and reduces serum levels of matrix metalloproteinases (MMPs), enzymes involved in pathological vascular remodeling and atherosclerotic plaque.

Particular physiopathological relevance is assumed by Equol, a non-steroidal metabolite produced by the intestinal bacterial flora from daidzein. Equol exists in two enantiomeric forms: (R)-equol and (S)-equol. The (S)-equol form possesses an elective and highly selective affinity for the β-estrogen receptor (ERβ). Comparative clinical studies conducted on women suffering from intense vasomotor symptoms (at least 8 hot flashes a day) have demonstrated a clear superiority of the administration of (S)-equol compared to raw isoflavones in significantly reducing both the frequency and severity of hot flashes.

Tree Nuts: Mineral and Electrolyte Support

Almonds, walnuts and hazelnuts represent an excellent source of bioavailable macro-minerals, in particular Calcium and Magnesium. The constant intake of this tree nut proves to be a fundamental nutritional strategy for women who do not consume dairy products due to dietary choices or lactose intolerance conditions (caused by a deficiency of the lactase enzyme, a symptom present in over 50% of the Caucasian population).

Magnesium acts as a cofactor in over 300 enzymatic reactions, regulating neuromuscular excitability and the HPA axis, while calcium incorporated into a balanced plant lipid matrix (rich in monounsaturated and polyunsaturated fatty acids) contributes to the maintenance of the bone architecture trophism, limiting the demineralization processes typical of the post-fertile age.

Bibliographic References

1. AACE/ACE Guidelines (2017). American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Menopause. Endocrine Practice.
2. FDA Safety Communication (2012). Risk of Venous Thromboembolism and Breast Cancer with Hormone Replacement Therapy.
3. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010). Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood cholesterol concentrations. EFSA Journal, 8(12):1885.
4. Davison, K. E., et al. (2014). Oat beta-glucan supplementation and lipid profile in postmenopausal obese women. Journal of Nutritional Biochemistry, 25(6), 678-685.
5. Weiss, D. J., & Anderton, C. R. (2003). Determination of catechins in matcha green tea by micellar electrokinetic chromatography. Journal of Chromatography A, 1011(1-2), 173-180.
6. Bose, M., et al. (2012). Effects of EGCG supplementation on metabolic parameters and bone health in postmenopausal women: A randomized controlled trial. American Journal of Clinical Nutrition, 96(5), 1120-1129.
7. Figueroa, A., et al. (2013). Watermelon extract supplementation reduces aortic blood pressure and arterial stiffness in postmenopausal women with hypertension. American Journal of Hypertension, 26(2), 290-299.
8. Setchell, K. D., et al. (2002). The clinical importance of the metabolite S-equol—a potent pro-estrogenic bioflavonoid. The Journal of Nutrition, 132(12), 3577-3584.
9. Jackson, R. L., et al. (2011). S-equol, a novel compound for the treatment of menopause symptoms: a pilot clinical study. Menopause, 18(9), 985-993.
10. Cicero, A. F., et al. (2007). Isoflavones and berberine combination in the management of dyslipidemia and menopausal symptoms in postmenopausal women. Phytomedicine, 14(11), 737-742.